RESUMO
To the Editor, Bladder cancer (BCa) is the second most common cancer in urological clinical practice, after prostate adenocarcinoma. Usually occurs in patients between 60 and 70 years old, three times more frequently in men than women. About 75% of bladder cancer are pTa or pT1, even more frequently considering a population younger than 40 years old. Early detection is of paramount importance since allows to find tumors when they are still superficial and therefore with a better prognosis.
Assuntos
Neoplasias da Próstata , Neoplasias da Bexiga Urinária , Masculino , Humanos , Pessoa de Meia-Idade , Idoso , Adulto , Pacientes Ambulatoriais , Neoplasias da Bexiga Urinária/patologia , Bexiga Urinária/patologia , Prognóstico , Recidiva Local de Neoplasia/cirurgiaRESUMO
To the Editor, The exact time to stop bladder cancer patient's follow-up is not well known and there is not a clear recommendation on if and when stop to follow a patient managed for muscle invasive bladder cancer (MIBC). Major urological guidelines do not provide a precise indication on the timing of follow-up, and there is currently no real consensus on optimal time schedule [...].